Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year

IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046



Soluble transcobalamin receptor, sCD320, is present in human serum and relates to serum cobalamin – establishment and validation of an ELISA

1 / Edward V. Quadros2 / Ebba Nexo1

1Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark

2Departments of Medicine and Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY, USA

Corresponding author: Johan Frederik Berg Arendt, Department of Clinical Biochemistry, Aarhus University Hospital, Norrebrogade 44, 8000 Aarhus C, Denmark Phone: +45 89 49 97 43, Fax: +45 89 49 30 60

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 50, Issue 3, Pages 515–519, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/cclm.2011.810, December 2011

Publication History

Published Online:


Background: The cell-surface receptor, TCblR/CD320, binds and internalizes transcobalamin-bound cobalamin. So far, no assay has been developed in order to quantify the soluble form of the receptor.

Methods: This study developed an ELISA employing a monoclonal antibody that recognized the extracellular domain of CD320 as capture antibody and a biotinylated polyclonal antibody for detection. Serum samples were analyzed from blood donors (n==153) and samples from patients referred for analysis of serum cobalamin [n=757, serum cobalamin 75–2000 pg/mL (55–1476 pmol/L)].

Results: The ELISA specifically measured soluble CD320 with a quantification limit of 1.6 arbitrary units and a total variation of 4%–8%. Size exclusion chromatography was used which showed that the immunoreactive protein observed in serum eluted in the same position as soluble CD320 in the calibrator. Male donors (n=76) showed significantly higher median concentration [18 arbitrary units (arb.u.)] than female donors (n=77, median 16 arb.u.), but the absolute difference was marginal and suggested that a common reference interval of 12–97 arb.u. can be used. A positive correlation was observed between levels of soluble CD320 and serum cobalamin with median levels increasing from 17 arb.u. [n=203, cobalamin 75–270 pg/mL (55–200 pmol/L)] to 23 arb.u. [n=350, cobalamin 814–2000 pg/mL (601–1476 pmol/L)], p<0.0001.

Conclusions: An ELISA was established for measurement of soluble CD320 and it was shown that the protein is present in human serum. The serum concentrations of soluble CD320 correlated positively with serum cobalamin levels.

Keywords: cobalamin; ELISA; protein markers; soluble membrane proteins; soluble transcobalamin receptor

Comments (0)

Please log in or register to comment.